A child presents with a perioral and arm rash and a strawberry (straw‑colored, enlarged) tongue; what is the most likely diagnosis and recommended immediate management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Kawasaki Disease: Diagnosis and Immediate Management

This child most likely has Kawasaki disease, and you must initiate intravenous immunoglobulin (IVIG) 2 g/kg as a single infusion plus high-dose aspirin (80–100 mg/kg/day divided into four doses) immediately to prevent coronary artery aneurysms. 1, 2

Diagnostic Reasoning

The combination of strawberry tongue, perioral rash, and arm rash in a febrile child strongly suggests Kawasaki disease. 3 The American Heart Association defines classic Kawasaki disease as fever ≥5 days plus ≥4 of 5 principal features: bilateral non-purulent conjunctival injection, oral changes (strawberry tongue, cracked lips), polymorphous rash, extremity changes (erythema/edema), and cervical lymphadenopathy ≥1.5 cm. 1, 2

Key Clinical Features Present:

  • Strawberry tongue (red, swollen tongue with prominent papillae) is one of the oral mucosal changes characteristic of Kawasaki disease 1, 2
  • Polymorphous rash on arms and perioral area fulfills the rash criterion 1, 2
  • These features, combined with fever, warrant immediate evaluation for Kawasaki disease even if other criteria are not yet apparent 1

Critical Diagnostic Pitfall:

Clinical features in Kawasaki disease appear sequentially, not simultaneously—you cannot wait for all 5 features to develop before treating. 2 If this child has had fever for ≥5 days with only 2–3 principal features, this represents incomplete Kawasaki disease, which carries the same risk of coronary complications as classic disease. 1, 2

Immediate Diagnostic Workup

Obtain these tests immediately while preparing for treatment: 1, 2

Laboratory Evaluation:

  • ESR and CRP to document inflammation (ESR typically ≥40 mm/hr, often >100 mm/hr; CRP ≥3 mg/dL) 2
  • Complete blood count (expect leukocytosis >15,000 cells/µL, neutrophilia, age-appropriate anemia, thrombocytosis after day 7) 2
  • Comprehensive metabolic panel (look for hypoalbuminemia ≤3.0 g/dL, elevated ALT) 2
  • Urinalysis (sterile pyuria >10 WBC/hpf is characteristic—do not mistake this for urinary tract infection) 2
  • SARS-CoV-2 PCR and serology to rule out MIS-C (Multisystem Inflammatory Syndrome in Children), which has overlapping features 1

Cardiac Imaging:

Urgent transthoracic echocardiogram is mandatory to assess for coronary artery involvement (z-score ≥2.5 for left anterior descending or right coronary artery indicates abnormality). 2 Early vasculitis signs include perivascular brightness, lack of tapering, and coronary ectasia. 2

Differential Diagnosis Considerations

Scarlet Fever:

Scarlet fever also presents with strawberry tongue, fever, and sandpaper-like rash, most common in children aged 5–15 years. 1, 4 Key distinguishing features:

  • Scarlet fever typically has pharyngeal exudate and responds to antibiotics 4
  • Kawasaki disease has diffuse oral/pharyngeal erythema WITHOUT exudates or ulcers 2
  • Obtain rapid strep test and throat culture to differentiate 4

MIS-C:

MIS-C presents with overlapping features but typically has more prominent GI symptoms, lower platelet counts, and higher CRP levels than classic Kawasaki disease. 1 Both conditions can cause coronary artery aneurysms and require similar urgent treatment. 1

Immediate Treatment Protocol

Treatment must be initiated within 10 days of fever onset to reduce coronary artery aneurysm risk from ~25% to ~5%. 2, 5, 6

First-Line Therapy:

  • IVIG 2 g/kg as a single infusion 2, 6
  • High-dose aspirin 80–100 mg/kg/day divided into four doses 2
  • High clinical suspicion justifies starting IVIG and aspirin before completing the full echocardiographic evaluation 2

If No Response to Initial IVIG:

If fever persists 36 hours after completing the first IVIG infusion, administer a second dose of IVIG 2 g/kg with or without corticosteroids. 5, 6

Special Populations at Highest Risk:

  • Infants <6 months with fever ≥7 days require echocardiography even with minimal clinical features due to highest risk of coronary abnormalities 2
  • Children with early coronary artery dilatation or extreme laboratory abnormalities should receive corticosteroids in addition to IVIG 7

Critical Management Pitfalls to Avoid

Do not dismiss incomplete Kawasaki disease in infants <1 year—this age group has the highest risk of coronary abnormalities and often presents with fewer than 4 principal features. 1, 2

Do not attribute rash to antibiotic reaction if the child was initially treated for presumed bacterial infection—this is a classic missed diagnosis scenario for Kawasaki disease. 1

Do not wait for conjunctivitis to appear—incomplete Kawasaki disease is more common in infants and can present without bilateral conjunctival injection. 1

Sterile pyuria should never be dismissed as a partially treated urinary tract infection—it is a characteristic finding in Kawasaki disease. 2

Hospital Admission Required

This child requires immediate hospitalization for multidisciplinary team involvement, serial cardiac monitoring, and IVIG therapy administration. 1 Coronary artery aneurysm is a lethal complication of Kawasaki disease and represents the leading cause of acquired heart disease in children. 3, 5

References

Guideline

Differential Diagnosis for Fever up to 40°C, Strawberry Tongue, and Rash

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Baseline Laboratory and Imaging Evaluation for Kawasaki Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Strawberry Tongue Causes and Diagnostic Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Diagnosis and management of kawasaki disease.

American family physician, 2015

Research

Intravenous immunoglobulin for the treatment of Kawasaki disease.

The Cochrane database of systematic reviews, 2023

Research

Kawasaki Disease at 50 Years.

JAMA pediatrics, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.